A researcher in the University of the Basque Country’s (UPV/EHU) Department of Communications Engineering has developed the Ladon security protocol, an efficient mechanism to authenticate, authorize and establish the end-to-end keys (keys for communication between the terminal used by the doctor and the patient's device) for ICDs.

Healthcare Supply Chain Association (HSCA) President Curtis Rooney released a statement on the annual Budget and Economic Outlook compiled by the Congressional Budget Office (CBO).

The British Medical Journal published results online that show Abbott’s Architect Stat High Sensitive Troponin-I (hsTnl) test may help doctors to detect twice as many myocardial infarctions (MI) in women. Results showed that Abbott’s test was able to diagnose MI in 22 percent of cases for women compared to a standard of 11 percent, when using a sex-specific threshold.

Biosensors International Group has announced a distribution agreement with Veryan Medical Ltd. for BioMimics 3D, a nitinol stent with three-dimensional helical geometry designed for use in the superficial femoral artery.

SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct a clinical study of the effectiveness of the SynCardia temporary Total Artificial Heart for permanent use, also called destination therapy.

Medtronic announced new results from the PainFree SST and Shock-Less clinical studies published in the journal HeartRhythm.

The 2014 Best in KLAS report ranks healthcare vendors and their solutions by the professionals who use them—healthcare providers.

Medtronic revealed new one-year clinical data showing that transcatheter aortic valve replacement (TAVR) with the self-expanding CoreValve System offers advantages in survival and safety compared to surgical aortic valve replacement (SAVR) in high risk aortic stenosis patients who have previously undergone coronary artery bypass grafting (CABG) surgery.